Local activation and inactivation of thyroid hormones: The deiodinase family

Molecular and Cellular Endocrinology

Volumn 151, Issue 1-2, 1999, Pages 103-119

  Köhrle, Josef ^a  

^a D 97070   (Germany)

Author keywords

Binding; Deiodinases; Euthyroid sick syndrome; Low T3 syndrome; Non thyroidal illness; Selenium; Thyroid hormone; Transport and metabolism of thyroid hormones; Uptake

Indexed keywords

CELL NUCLEUS RECEPTOR; IODIDE PEROXIDASE; LEVOTHYROXINE; LIOTHYRONINE; SELENIUM; SELENOCYSTEINE; THYROID HORMONE; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; CONJUGATION; DEIODINATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HORMONE ACTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THYROID HORMONE METABOLISM; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

EID: 0142214992     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00040-4     Document Type: Article

References (152)

1. Abe T., Kakyo M., Sakagami H., Tokui T., Nishio T., Tanemoto M., Nomura H., Hebert H., Matsuno S., Kondo H., Yawo H. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J. Biol. Chem. 273:1998;22395-22401.
2. Anderson S. 17β-hydroxysteroid dehydrogenase: isoenzymes and mutations. J. Endocrinol. 147:1995;197-200.
3. Arem R., Wiener G.J., Kaplan S.G., Kim H.S., Reichlin S., Kaplan M.M. Reduced tissue thyroid hormone levels in fatal illness. Metabolism. 42:1993;1102-1108.
4. Arthur J.R., Nicol F., Beckett G.J. Hepatic iodothyronine 5′-deiodinase. The role of selenium. Biochem. J. 272:1990;537-540.
5. Auf dem Brinke D., Hesch R.D., Köhrle J. Re-examination of the subcellular localization of thyroxine-5′-deiodination in rat liver. Biochem. J. 180:1979;273-279.
6. Balsam A., Ingbar S.H. Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and nature of the defect induced by fasting. J. Clin. Invest. 63:1979;1145-1156.
7. Bartalena L., Bogazzi F., Brogioni S., Grasso L., Martino E. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur. J. Endocrinol. 138:1998;603-614.
8. Baumgartner A., Hiedra L., Pinna G., Eravci M., Prengel H., Meinhold H. Rat brain type II 5′-deiodinase activity is extremely sensitive to stress. J. Neurochem. 71:1998;817-826.
9. Baur A., Bauer K., Jarry H., Köhrle J. 3,5-Di-iodo-L-thyronine stimulates type I 5'- deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro. Endocrinology. 138:1997;3242-3248.
10. Baur, A., Köhrle, J., 1997. GX cells: a human cell model for investigations of immuno-endocrine interactions at the pituitary level. Exp. Clin. Endocrinol. Diabetes 105, 1-1 (Abstract).
11. Baur, A., Köhrle, J., 1999. Type I 5′-deiodinase is stimulated by iodothyronines and involved in thyroid hormone metabolism in human somatomammotroph GX cells. Eur. J. Endocrinol. 140 (in press).
12. Becker K.B., Stephens K.C., Davey J.C., Schneider M.J., Galton Y.A. The type 2 and type 3 iodothyronine deiodinases play important roles in coordinating development in Rana catesbeiana tadpoles. Endocrinology. 138:1997;2989-2997.
13. Beech S.G., Walker S.W., Arthur J.R., Lee D., Beckett G.J. Differential control of type-I iodothyronine deiodinase expression by the activation of the cyclic AMP and phosphoinositol signalling pathways in cultured human thyrocytes. J. Mol. Endocrinol. 14:1995;171-177.
14. Behne D., Kyriakopoulos A., Meinhold H., Köhrle J. Identification of type I iodothyronine 5′-deiodinase as a selenoenzyme. Biochem. Biophys. Res. Commun. 173:1990;1143-1149.
15. Bernal J., Nunez J. Thyroid hormones and brain development. Eur. J. Endocrinol. 133:1995;390-398.
16. Berry M.J. Identification of essential histidine residues in rat type I iodothyronine deiodinase. J. Biol. Chem. 267:1992;18055-18059.
17. Berry M.J., Banu L., Larsen P.R. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature. 349:1991;438-440.
18. Berry M.J., Kieffer J.D., Harney J.W., Larsen P.R. Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. J. Biol. Chem. 266:1991;14155-14158.
19. Berthon D., Herpin P., Duchamp C., Dauncey M.J., Le Dividich J. Modification of thermogenic capacity in neonatal pigs by changes in thyroid status during late gestation. J. Dev. Physiol. 19:1993;253-261.
20. Berthon D., Herpin P., Le Dividich J., Dauncey M.J. Interactive effects of thermal environment and energy intake on thyroid hormone metabolism in newborn pigs. Biol. Neonate. 69:1996;51-59.
21. Borges M., Ingbar S.H., Silva J.E. Iodothyronine deiodinase activities in FRTL-5 cells: predominance of type I 5′-deiodinase. Endocrinology. 126:1990;3059-3068.
22. Buettner C., Harney J.W., Larsen P.R. The 3′-untranslated region of human type 2 iodothyronine deiodinase mRNA contains a functional selenocysteine insertion sequence element. J. Biol. Chem. 273:1998;33374-33378.
23. Burmeister L.A., Pachucki J., Germain D.L.S. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology. 138:1997;5231-5237.
24. Calvo R.M., Roda J.M., Obregon M.J., Morreale de Escobar G. Thyroid hormones in human tumoral and normal nervous tissues. Brain Res. 801:1998;150-157.
25. Campos Barros A., Hoell T., Musa A., Sampaolo S., Stoltenburg G., Pinna G., Eravci M., Meinhold H., Baumgartner A. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system. J. Clin. Endocrinol. Metab. 81:1996;2179-2185.
26. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. New Engl. Journal. Med. 337:1997;91-95.
27. Celi F.S., Canettieri G., Yarnall D.P., Burns D.K., Andreoli M., Shuldiner A.R., Centanni M. Genomic characterization of the coding region of the human type II 5′-deiodinase gene. Mol. Cell Endocrinol. 14:1998;49-52.
28. Celotti F., Negri-Cesi P., Poletti A. Steroid metabolism in the mammalian brain: 5-alpha-reduction and aromatization. Brain Res. Bull. 44:1997;365-375.
29. Chanoine J.P., Braverman L.E., Farwell A.P., Safran M., Alex S., Dubord S., Leonard J.L. The thyroid gland is a major source of circulating T3 in the rat. J. Clin. Invest. 91:1993;2709-2713.
30. Chomczynski P., Soszynski P.A., Frohman L.A. Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line. J. Clin. Endocrinol. Metab. 77:1993;281-285.
31. Chopra, I.J., 1996. Nature, source, and relative significance of circulating thyroid hormones. In: Braverman, L.E., Utiger R.D. (Eds.), Werner and Ingbar's The Thyroid, 7th ed. (7). Lippincott-Raven, Philadelphia, pp. 111-124.
32. Croteau W., Bodwell J.E., Richardson J.M., St. Germain D.L. Conserved cysteines in the type 1 deiodinase selenoprotein are not essential for catalytic activity. J. Biol. Chem. 273:1998;25230-25236.
33. Davey J.C., Becker K.B., Schneider M.J., St. Germain D.L., Galton V.A. Cloning of a cDNA for the type II iodothyronine deiodinase. J. Biol. Chem. 270:1995;26786-26789.
34. Davis, P.J., 1991. Cellular actions of thyroid hormones. In: Braverman, L.E., Utiger, R.D. (Eds.), Werner and Ingbar's The Thyroid, 6 ed. (9). Lippincott-Raven, Philadelphia, pp. 190-203.
35. Davis P.J., Davis F.B. Nongenomic actions of thyroid hormone. Thyroid. 6:1996;497-504.
36. Docter R., Friesema E.C.H., van Stralen P.G.J., Krenning E.P., Everts M.E., Visser T.J., Hennemann G. Expression of rat liver cell membrane transporters for thyroid hormone in Xenopus laevis oocytes. Endocrinology. 138:1997;1841-1846.
37. Dutkiewicz S., Witeska A., Nauman A. The deiodination of thyroxine to triiodothyronine in the testes of patients with prostate cancer. Int. Urol. Nephrol. 27:1995;81-85.
38. Escobar-Morreale H.F., Escobar del Rey F., Obregón M.J., Morreale de Escobar G. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology. 137:1996;2490-2502.
39. Everts M.E., De Jong M., Lim C.-F., Docter R., Krenning E.P., Visser T.J., Hennemann G. Different regulation of thyroid hormone transport in liver and pituitary: its possible role in the maintenance of low T3 production during nonthyroidal illness and fasting in man. Thyroid. 6:1996;359-368.
40. Fekkes D., van Overmeeren-Kaptein E., Docter R., Hennemann G., Visser T.J. Location of rat liver iodothyronine deiodinating enzymes in the endoplasmic reticulum. Biochim. Biophys. Acta. 587:1979;12-19.
41. Frith S.D., Eales J.G. Thyroid hormone deiodination pathways in brain and liver of rainbow trout, Oncorhynchus mykiss. Gen. Comp. Endocrinol. 101:1996;323-332.
42. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., Portale A.A. Cloning of human 25-hydroxy-vitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 11:1997;1961-1970.
43. Garcia Macias J.F., Molinero P., Guerrero J.M., Osuna C. Expression of type II thyroxine 5′-deiodinase from rat harderian gland in Xenopus laevis oocytes. FEBS Lett. 354:1994;110-112.
44. Glorieux F.H., St. Arnaud R. Molecular cloning of (25-OH-D)-1 alpha-hydroxylase: an approach to the understanding of vitamin D pseudo-deficiency. Recent Prog. Horm. Res. 53:1998;341-349.
45. Gondou A., Toyoda N., Nishikawa M., Tabata S., Yonemoto T., Ogawa Y., Tokoro T., Sakaguchi N., Wang F., Inada M. Induction of type 2 deiodinase activity by cyclic guanosine 3,3′-monophosphate in cultured rat glial cells. Thyroid. 8:1998;615-622.
46. Goumaz M.O., Kaiser C.A., Burger A.G. Brain cortex reverse triiodothyronine (rT3) and triiodothyronine concentrations under steady state infusions of thyroxine and rT3. Endocrinology. 120:1987;1590-1596.
47. Guadano-Ferraz A., Bernal J. Regional expression of 5′-deiodinase II in the rat brain as studied by in situ hybridization. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10391-10396.
48. Hernandez A., Obregon M.J. T3 potentiates the adrenergic stimulation of type II 5′-deiodinase activity in cultured rat brown adipocytes. Am. J. Physiol. 271:1996;E15-E23.
49. Hernandez A., Park J.P., Lyon G.J., Mohandas T.K., St. Germain D.L. Localization of the type 3 iodothyronine deiodinase (DIO3) gene to human chromosome 14q32 and mouse chromosome 12F1. Genomics. 53:1998;119-121.
50. Himms Hagen J. Does thermoregulatory feeding occur in newborn infants? A novel view of the role of brown adipose tissue thermogenesis in control of food intake. Obes. Res. 3:1995;361-369.
51. Holick M.F. Defects in the synthesis and metabolism of vitamin D. Exp. Clin. Endocrinol. Diabetes. 103:1995;219-227.
52. Hoogma R.P.L.M., Van der Heide D. Amiodarone and thyroid function. Neth. J. Med. 36:1990;209-216.
53. Ishii H., Inada M., Tanaka K., Mashio Y., Naito K., Nishikawa M., Matsuzuka F., Kuma K., Imura H. Induction of outer and inner ring monodeiodinases in human thyroid gland by thyrotropin. J. Clin. Endocrinol. Metab. 57:1983;500-505.
54. Jakob F., Siggelkow H., Homann D., Köhrle J., Adamski J., Schütze N. Local estradiol metabolism in osteoblast- and osteoclast-like cells. J. Steroid Biochem. Mol. Biol. 61:1997;167-174.
55. Jakobs, T., Schmutzler, C., Köhrle, J., 1995. Identification of a T3 responsive element in the upstream regulatory region of the human type I 5′-deiodinase gene. Thyroid 5, S130 (Abstract).
56. Jakobs T., Schmutzler C., Meissner J., Köhrle J. The promotor of the human type I 5′-deiodinase gene: mapping of the transcription start site and identification of a DR+4 thyroid hormone responsive element. Eur. J. Biochem. 247:1997;288-297.
57. Jakobs T.C., Koehler M.R., Schmutzler C., Glaser F., Schmid M., Köhrle J. Structure of the human type I iodothyronine 5′-deiodinase gene and localization to chromosome 1p32-p33. Genomics. 42:1997;361-363.
58. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXRα Nature. 383:1996;728-731.
59. Kaiser C.A., Goumaz M.O., Burger A.G. In vivo inhibition of the 5′-deiodinase type II in brain cortex and pituitary by reverse triiodothyronine. Endocrinology. 119:1986;762-770.
60. Kaplan M.M., Pan C.Y., Gordon P.R., Lee J.K., Gilchrest B.A. Human epidermal keratinocytes in culture convert thyroxine to 3,5,3′-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin. J. Clin. Endocrinol. Metab. 66:1988;815-822.
61. Kaminski T., Köhrle J., Ködding R., Hesch R.D. Autoregulation of 3,3′,5′-triiodothyronine production by rat liver microsomes. Acta Endocrinol. 98:1981;240-245.
62. Kim S.W., Harney J.W., Larsen P.R. Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic aacid in pituitary tumor cells using semiquantitative reverse transcription polymerase reaction. Endocrinology. 139:1998;4895-4905.
63. Koenig R.J., Leonard J.L., Senator D., Rappaport N., Watson A., Larsen P.R. Regulation of thyroxine 5′-deiodinase activity by 3,5,3′-triiodothyronine in cultured anterior pituitary cells. Endocrinology. 115:1984;324-329.
64. Köhrle J. Thyrotropin (TSH) action on thyroid hormone deiodination and secretion: one aspect of thyrotropin regulation of thyroid cell biology. Horm. Metab. Res. 23(Suppl.):1990;18-28.
65. Köhrle J. Thyroid hormone deiodinases: a selenoenzyme family acting as gate keepers to thyroid hormone action. Acta Med. Austriaca. 23:1996;17-30.
66. Köhrle J. Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I 5′-deiodinase and the expression of thyroid hormone receptors and other thyroid-specific (de-)differentiation markers. Curr. Top. Pathol. 91:1997;83-116.
67. Köhrle, J., 1999. The trace element selenium and the thyroid gland. Biochimie (in press).
68. Köhrle J., Auf'mkolk M., Rokos H., Hesch R.D., Cody V. Rat liver iodothyronine monodeiodinase: evaluation of the iodothyronine binding site. J. Biol. Chem. 261:1986;11613-11622.
69. Köhrle, J., Hesch, R.D., 1984. Biochemical characteristics of iodothyronine monodeiodination by rat liver microsomes: the interaction between iodothyronine substrate analogues and the ligand binding site of iodothyronine deiodinase resembles that of the TBPA-iodothyronine ligand binding site Horm. Metab. Res. 14 (Suppl. Ser.), 42-55.
70. Köhrle, J., Hesch, R.D., Leonard, J.L., 1991. Intracellular pathways of iodothyronine metabolism. In: Braverman, L.E., Utiger, R.D. (Eds.), Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 6th ed. (8). Lippincott-Raven, Philadelphia, pp. 144-189.
71. Köhrle, J., Jakobs, T.C., Schmutzler, C., 1997. Genetics of iodothyronine deiodinase enzymes. Thyroid 7, 687-687 (Abstract).
72. Köhrle J., Oertel M., Hoang-Vu C., Schnieders F., Brabant G. Type I 5′-deiodinase: a marker for differentiated thyroid carcinoma? Exp. Clin. Endocrinol. 101(Suppl. 3):1993;60-72.
73. Köhrle J., Schomburg L., Drescher S., Fekete E., Bauer K. Rapid stimulation of type I 5′-deiodinase in rat pituitaries by 3,3′,5-triiodo-L-thyronine. Mol. Cell. Endocrinol. 108:1995;17-21.
74. Kragie L. Membrane iodothyronine transporters part I: review of physiology. Endocr. Res. 20:1994;319-341.
75. Kragie L. Membrane iodothyronine transporters part II: review of protein biochemistry. Endocr. Res. 22:1996;95-119.
76. Lanni A., Moreno M., Lombardi A., Goglia F. Calorigenic effect of diiodothyronines in the rat. J. Physiol. (Lond.). 494:1996;831-837.
77. Larsen P.R., Silva J.E., Kaplan M.M. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr. Rev. 2:1981;87-102.
78. Laurberg P. Iodothyronine release from the perfused canine thyroid. Kopenhagen Acta Endocrinol. Suppl. 236:1980;1-50.
79. Lee W.S., Berry M.J., Hediger M.A., Larsen P.R. The type I iodothyronine 5′-deiodinase messenger ribonucleic acid is localized to the S3 segment of the rat kidney proximal tubule. Endocrinology. 132:1993;2136-2140.
80. Leonard, J.L., 1991. Identification and structure analysis of iodothyronine deiodinases. In: Greer, M.A. (Ed.), The Thyroid Gland (9). Raven Press, New York, pp. 285-321.
81. Leonard J.L., Ekenbarger D.M., Frank S.J., Farwell A.P., Köhrle J. Localization of type I iodothyronine 5′ deiodinase to the basolateral plasma membrane of rat kidney and LLC-PK1 renal cortical cells. J. Biol. Chem. 266:1991;11262-11269.
82. Leonard J.L., Farwell A.P. Thyroid hormone-regulated actin polymerization in brain. Thyroid. 7:1997;147-151.
83. Leonard, J.L., Köhrle, J., 1996. Intracellular pathways of iodothyronine metabolism. In: Braverman, L.E., Utiger, R.D. (Eds.), Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 7th ed. (8). Lippincott-Raven, Philadelphia, pp. 125-161.
84. Leonard, J.L., Safran, M., Farwell, A.P., 1997. Type II iodothyronine deiodinase (IDII) in astrocytes is not encoded by the 7.5 kb IDII mRNA. Program and Abstracts 79th Annual Meeting of the Endocrine Society, 293-293 (Abstract).
85. Liang H., Juge-Aubry C.E., O'Connell M., Burger A.G. Organ-specific effects of 3,5,3′-triiodothyroacetic acid in rats. Eur. J. Endocrinol. 137:1997;537-544.
86. LoPresti J.S., Eigen A., Kaptein E., Anderson K.P., Spencer C.A., Nicoloff J.T. Alterations in 3,3′,5′-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J. Clin. Invest. 84:1989;1650-1656.
87. Maia A.L., Berry M.J., Sabbag R., Harney J.W., Larsen P.R. Structural and functional differences in the dio 1 gene in mice with inherited type 1 deiodinase deficiency. Mol. Endocrinol. 9:1995;969-980.
88. McIver B., Gorman C.A. Euthyroid sick syndrome: an overview. Thyroid. 7:1997;125-132.
89. Meinhold H., Gramm H.-J., Meissner W., Zimmermann J., Schwander J., Dennhardt R., Voigt K. Elevated serum diiodotyrosine (DIT) in severe infections and sepsis: DIT, a possible new marker of leukocyte activity. J. Clin. Endocrinol. Metab. 72:1991;945-953.
90. Menjo M., Murata Y., Fujii T., Nimura Y., Seo H. Effects of thyroid and glucocorticoid hormones on the level of messenger ribonucleic acid for iodothyronine type I 5′-deiodinase in rat primary hepatocyte cultures grown as spheroids. Endocrinology. 133:1993;2984-2990.
91. Mitchell J.H., Nicol F., Beckett G.J., Arthur J.R. Selenoenzyme expression in thyroid and liver of second generation selenium- and iodine-deficient rats. J. Mol. Endocrinol. 16:1996;259-267.
92. Miyashita K., Murakami M., Iriuchijiama T., Takeuchi T., Mori M. Regulation of rat liver type 1 iodothyronine deiodinase mRNA levels by testosterone. Mol. Cell Endocrinol. 115:1995;161-167.
93. Mori K., Stone S., Braverman L.E., DeVito W.J. Effects of ceramide and protein kinase c on the regulation of type I 5′-deiodase in FRTL-5 rat thyroid cells. Endocrinology. 137:1996;4994-4999.
94. Müller M.J., Köhrle J., Hesch R.D., Seitz H.J. Effect of cycloAMP on iodothyronine metabolism in the isolated perfused rat liver. Biochem. Int. 5:1982;495-501.
95. Napoli J.L., Boerman M.H., Chai X., Zhai Y., Fiorella P.D. Enzymes and binding proteins affecting retinoic acid concentrations. J. Steroid Biochem. Mol. Biol. 53:1995;497-502.
96. Naumann, A., Naumann, J., Witeska, A., Dutkiewicz, M., 1993. 5′-Deiodinase type I in human kidney cancer. J. Endocrinol. Invest. 16 (Suppl. 2), 76-76 (Abstract).
97. Nguyen, T.T., Chapa, F., DiStefano, J.J., III, 1998. Direct measurement of the contributions of type I and type II 5′-deiodinases to whole body steady state 3,5,3′-triiodothyronine production from thyroxione in the rat. Endocrinology 139, 4626-4633.
98. Nicol F., Lefranc H., Arthur J.R., Trayhurn P. Characterization and postnatal development of 5′-deiodinase activity in goat perirenal fat. Am. J. Physiol. 267:1994;144R-149R.
99. Oppenheimer, J.H., Schwartz, H.L., Strait, K.A., 1996. The molecular basis of thyroid hormone actions. In: Braverman, L.E., Utiger, R.D. (Eds.), Werner and Ingbar's The Thyroid, 7th ed. (9). Lippincott-Raven, Philadelphia, pp. 162-184.
100. Pazos-Moura C.C., Moura E.G., Dorris M.L., Rehnmark S., Melendez L., Silva J.E., Taurog A. Effect of iodine deficiency and cold exposure on thyroxine 5′-deiodinase activity in various rat tissues. Am. J. Physiol. 260:1991;E175-E182.
101. Pekary A.E., Chopra I.J., Berg L., Hershman J.M. Sphingomyelinase and phospholipase A2 regulate type I deiodase expression in FRTL-5 cells. Thyroid. 7:1997;647-654.
102. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr. Rev. 18:1997;281.
103. Pillar T.M., Seitz H.J. Thyroid hormone and gene expression in the regulation of mitochondrial respiratory function. Eur. J. Endocrinol. 136:1997;231-239.
104. Pinna G., Meinhold H., Hierda L., Thoma R., Hoell T., Gräf K.-J., Stoltenburg-Didinger G., Eravci M., Prengel H., Brödel O., Finke R., Baumgartner A. Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. J. Clin. Endocrinol. Metab. 82:1997;1535-1542.
105. Richard K., Hume R., Kaptein E., Sanders J.P., Van Toor H., De Herder W.W., den Hollander J.C., Krenning E., Visser T.J. Ontogeny of iodothyronine deiodinases in human liver. J. Clin. Endocrinol. Metab. 83:1998;2868-2874.
106. Robbins, J., 1996. Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman, L.E., Utiger, R.D. (Eds.), Werner and Ingbar's The Thyroid, 7th ed. (6). Lippincott-Raven, Philadelphia, pp. 96-110.
107. Rosenberg I.N., Goswami A. Purification and characterization of a flavoprotein from bovine thyroid with iodotyrosine deiodinase activity. J. Biol. Chem. 254:1979;12318-12325.
108. Rubio A., Menendez Pelaez A., Reiter R.J. Thyroxine 5′-deiodinase type II activity in chick pineal and Harderian gland: nyctohemeral rhythmicity and its regulation by noradrenergic input. J. Pineal Res. 14:1993;53-59.
109. Safran M., Farwell A.P., Leonard J.L. Catalytic activity of type II iodothyronine 5′-deiodinase polypeptide is dependent upon a cyclic AMP activation factor. J. Biol. Chem. 271:1996;16363-16368.
110. Salvatore D., Bartha T., Harney J.W., Larsen P.R. Molecular biological and biochemical charcterization of the human type 2 selenodeiodinase. Endocrinology. 137:1996;3308-3315.
111. Salvatore D., Tu H., Harney J.W., Larsen P.R. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J. Clin. Invest. 98:1996;962-968.
112. Sanders J.P., Van Der Geyten S., Kaptein E., Darras V.M., Kühn E.R., Leonard J.L., Visser T.J. Characterization of a propylthiouracil-intensitive type I iodothyronine deiodinase. Endocrinology. 138:1997;5153-5160.
113. Santini F., Chiovato L., Lapi P., Lupetti M., Dolfi A., Bianchi F., Bernardini N., Bendinelli G., Mammoli C., Vitti P., Chopra I.J., Pinchera A. The location and the regulation of the type I-iodothyronine 5′-monodeiodinase (type I-MD) in the rat thyroid: studies using a specific anti-type I-MD antibody. Mol. Cell Endocrinol. 110:1995;195-203.
114. Schmutzler C., Brtko J., Bienert K., Köhrle J. Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom. Exp. Clin. Endocrinol. Diabetes. 104:1996;16-19.
115. Schmutzler, C., Jakobs, T.C., Dreher, I., Glaser, F., Köhrle, J., 1998a. Regulation of type I 5′-deiodinase (5′DI) by proinflammatory cytokines in the human hepatocarcinoma cell line HepG2. J. Endocrinol. Invest. 21, 2-2 (Abstract).
116. Schmutzler, C., Jakobs, T.C., Wagner, C., Glaser, F., Meissner-Weigl, J., Köhrle, J., 1998b. RA- and T3-dependent activation of the human type I 5′-deiodinase promoter is mediated by bifunctional hormone responsive elements in a cell type-specific manner (submitted).
117. Schreck R., Schnieders F., Schmutzler C., Köhrle J. Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 79:1994;791-798.
118. Schreiber G., Richardson S.J. The evolution of gene expression, structure and function of transthyretin. Comp. Biochem. Physiol. B. 116:1997;137-160.
119. Schröder van der Elst J.P., Van der Heide D., Rokos H., Köhrle J., Morreale de Escobar G. Different tissue distribution, elimination, and kinetics of thyroxine and its conformational analog, the synthetic flavonoid EMD 49209 in the rat. Endocrinology. 138:1997;79-84.
120. Schröder van der Elst J.P., Van der Heide D., Morreale de Escobar G., Obregón M.J. Iodothyronine deiodinase activities in fetal rat tissues at several levels of iodine deficiency: a role for the skin in 3,5,3′-triiodothyronine economy? Endocrinology. 139:1998;2229-2234.
121. Schröder van der Elst J.P., Van der Heide D., Rokos H., Morreale de Escobar G., Köhrle J. Synthetic flavonoids cross the placenta in the rat and are found in fetal brain. Am. J. Physiol. 274:1998;E253-E256.
122. Selmi-Ruby S., Rousset B. Analysis of the functional state of T3 nuclear receptors expressed in thyroid cells. Mol. Cell. Endocrinol. 119:1996;95-104.
123. Shen D.-C., Wu S.-Y., Chopra I.J., Huang H.-W., Shian L.-R., Bian T.-Y., Jeng C.-Y., Solomon D.H. Long term treatment of Graves' hyperthyroidism with sodium ipodate. J. Clin. Endocrinol. Metab. 61:1985;723-727.
124. Silva J.E. Thyroid hormone control of thermogenesis and energy balance. Thyroid. 5:1995;481-492.
125. Sonneveld E., Van der Saag P.T. Metabolism of retinoic acid: implications for development and cancer. Int. J. Vitam. Nutr. Res. 68:1998;404-410.
126. Soutto M., Guerrero J.M., Molinero P. Beta- and alpha-adrenergic mechanisms are involved in regulating type II thyroxine 5′-deiodinase in rat thymus. Life Sci. 58:1996;1-8.
127. Spanka M., Hesch R.-D., Irmscher K., Köhrle J. 5′-Deiodination in rat hepatocytes: effects of specific flavonoid inhibitors. Endocrinology. 126:1990;1660-1667.
128. Sporn, M.B., Roberts, A.B., Goodman,D.S. 1994. The Retinoids: Biology, Chemistry, and Medicine, 2nd ed. Raven Press, New York.
129. St. Germain D.L., Croteau W. Ligand-induced inactivation of type I iodothyronine 5′-deiodinase: protection by propylthiouracil in vivo and reversibility in vitro. Endocrinology. 125:1989;2735-2744.
130. St. Germain D.L., Galton V.A. The deiodinase family of selenoproteins. Thyroid. 7:1997;655-668.
131. Stulp M.R., De Vijlder J.J.M., Ris-Stalpers C. Placental iodothyronine deiodinase III and II ratios, mRNA expression compared to enzyme activity. Mol. Cell Endocrinol. 142:1998;67-73.
132. Sun B.C., Harney J.W., Marla J.B., Larsen P.R. The role of the active site cysteine in catalysis by type1 iodothyronine deiodinase. Endocrinology. 138:1997;5452-5458.
133. Toyoda N., Harney J.W., Berry M.J., Larsen P.R. Identification of critical amino acids for 3,5,3′-triiodothyronine deiodination by human type 1 deiodinase based on comparative functional-structural analyses of the human, dog, and rat enzymes. J. Biol. Chem. 269(32):1994;20329-20334.
134. Toyoda N., Kaptein E., Berry M.J., Harney J.W., Larsen P.R., Visser T.J. Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases. Endocrinology. 138:1997;213-219.
135. Toyoda N., Nishikawa M., Horimoto M., Yoshikawa N., Mori Y., Yoshimura M., Masaki H., Tanaka K., Inada M. Synergistic effect of thyroid hormone and thyrotropin on iodothyronine 5′-deiodinase in FRTL-5 rat thyroid cells. Endocrinology. 127:1990;1199-1205.
136. Toyoda N., Nishikawa M., Mori Y., Gondou A., Ogawa Y., Yonemoto T., Yoshimura M., Masaki H., Inada M. Thyrotropin and triiodothyronine regulate iodothyronine 5′-deiodinase messenger ribonucleic acid levels in FRTL-5 rat thyroid cells. Endocrinology. 131:1992;389-394.
137. Toyoda N., Zavacki A.M., Maia A.L., Harney J.W., Larsen P.R. A novel retinoid X receptor-indepent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol. Cell Biol. 15:1995;5100-5112.
138. Trayhurn P., Thomas M.E., Duncan J.S., Nicol F., Arthur J.R. Presence of the brown fat-specific mitochondrial uncoupling protein and iodothyronine 5′-deiodinase activity in subcutaneous adipose tissue of neonatal lambs. FEBS Lett. 322:1993;76-78.
139. Valverde C., Croteau W., Lafleur G.J., Orozco A., Germain D.L.S. Cloning and expression of a 5′-iodothyronine deiodinase from the liver of Fundulus heteroclitus. Endocrinology. 138:1997;642-648.
140. Van Beeren H.C., Bakker O., Wiersinga W.M. Structure-function relationship of the inhibition of the 3,5,3′-triiodothyronine binding to the α1- and β1-thyroid hormone receptor by amiodarone analogs. Endocrinology. 137:1996;2807-2814.
141. Van Do N., LeMar H., Reed H.L. Thyroid hormone responses to environmental cold exposure and seasonal changes: a proposed model. Endocrinol. Metab. 3:1996;7-16.
142. van Doorn J., Roelfsema F., Van der Heide D. Concentrations of thyroxine and 3,5,3′-triiodothyronine at 34 different sites in euthyroid rats as determined by an isotopic equilibrium technique. Endocrinology. 117:1985;1201-1208.
143. van Wassenaer A.G., Kok J.H., Dekker F.W., Endert E., De Vijlder J.J.M. Thyroxine administration to infants of less than 30 weeks gestational age decreases plasma tri-iodothyronine concentrations. Eur. J. Endocrinol. 139:1998;508-515.
144. Villette S., Bermano G., Arthur J.R., Hesketh J.E. Thyroid stimulating hormone and selenium supply interact to regulate selenoenzyme gene expression in thyroid cels (FRTL-5) in culture. FEBS Lett. 438:1998;81-84.
145. Visser T.J. Role of sulfation in thyroid hormone metabolism. Chem. Biol. Interact. 92:1994;293-303.
146. Visser T.J., Kaplan M.M., Leonard J.L., Larsen P.R. Evidence for two pathways of iodothyronine 5′ deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J. Clin. Invest. 71:1983;992-1002.
147. Visser T.J., Kaptein E., Glatt H., Bartsch I., Hagen M., Coughtrie M.W.H. Characterization of thyroid hormone sulfotransferases. Chem. Biol. Interact. 109:1998;279-291.
148. Vos R.A., De Jong M., Bernard B.F., Docter R., Krenning E.P., Hennemann G. Impaired thyroxine and 3,5,3′-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. J. Clin. Endocrinol. Metab. 80:1995;2364-2370.
149. White P.C., Mune T., Agarwal A.K. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18:1997;135-156.
150. Wilson J.D., Griffin J.E., Russel D.W. Steroid 5α-reductase 2 deficiency. Endocr. Rev. 14:1993;577-593.
151. Winzer R., Schmutzler C., Jakobs T.C., Ebert R., Rendl J., Reiners C., Köhrle J. RT-PCR analysis of thyrocyte-relevant genes in fine-needle aspiration biopsies of the human thyroid. Thyroid. 8:1998;981-987.
152. Zhang C.-Y., Kim S., Harney J.W., Larsen P.R. Further characterization of thyroid hormone response elements in the human type 1 iodothyronine deiodinase gene. Endocrinology. 139:1998;1156-1163.